Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Chan, Arlene, Prof, Delaloge, Suzette, MD, Holmes, Frankie A, MD, Moy, Beverly, MD, Iwata, Hiroji, MD, Harvey, Vernon J, MD, Robert, Nicholas J, MD, Silovski, Tajana, MD, Gokmen, Erhan, MD, von Minckwitz, Gunter, Prof, Ejlertsen, Bent, MD, Chia, Stephen K L, MD, Mansi, Janine, MD, Barrios, Carlos H, Prof, Gnant, Michael, Prof, Buyse, Marc, ScD, Gore, Ira, MD, Smith, John, MD, Harker, Graydon, MD, Masuda, Norikazu, MD, Petrakova, Katarina, MD, Zotano, Angel Guerrero, MD, Iannotti, Nicholas, MD, Rodriguez, Gladys, MD, Tassone, Pierfrancesco, Prof, Wong, Alvin, PharmD, Bryce, Richard, MBChB, Ye, Yining, PhD, Yao, Bin, MS, Martin, Miguel, Prof
Published in The lancet oncology (01.03.2016)
Published in The lancet oncology (01.03.2016)
Get full text
Journal Article
Patterns of occurrence and implications of neratinib-associated diarrhea in patients with HER2-positive breast cancer: analyses from the randomized phase III ExteNET trial
Mortimer, Joanne, Di Palma, Jack, Schmid, Kendra, Ye, Yining, Jahanzeb, Mohammad
Published in Breast cancer research : BCR (27.02.2019)
Published in Breast cancer research : BCR (27.02.2019)
Get full text
Journal Article
PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial
Chia, Stephen K L, Martin, Miguel, Holmes, Frankie A, Ejlertsen, Bent, Delaloge, Suzette, Moy, Beverly, Iwata, Hiroji, von Minckwitz, Gunter, Mansi, Janine, Barrios, Carlos H, Gnant, Michael, Tomašević, Zorica, Denduluri, Neelima, Šeparović, Robert, Kim, Sung-Bae, Jakobsen, Erik Hugger, Harvey, Vernon, Robert, Nicholas, Smith, 2nd, John, Harker, Graydon, Zhang, Bo, Eli, Lisa D, Ye, Yining, Lalani, Alshad S, Buyse, Marc, Chan, Arlene
Published in Breast cancer research : BCR (11.03.2019)
Published in Breast cancer research : BCR (11.03.2019)
Get full text
Journal Article
Predictors of habitual snoring and obstructive sleep apnea risk in patients with asthma
Teodorescu, Mihaela, Consens, Flavia B, Bria, William F, Coffey, Michael J, McMorris, Marc S, Weatherwax, Kevin J, Palmisano, John, Senger, Carolyn M, Ye, Yining, Kalbfleisch, Jack D, Chervin, Ronald D
Published in Chest (01.05.2009)
Published in Chest (01.05.2009)
Get more information
Journal Article
Phase 1b Study of Motesanib, an Oral Angiogenesis Inhibitor, in Combination with Carboplatin/Paclitaxel and/or Panitumumab for the Treatment of Advanced Non–Small Cell Lung Cancer
BLUMENSCHEIN, George R, RECKAMP, Karen, STEPHENSON, G. Joe, O'ROURKE, Timothy, GLADISH, Gregory, MCGREIVY, Jesse, SUN, Yu-Nien, YINING YE, PARSON, Mandy, SANDLER, Alan
Published in Clinical cancer research (01.01.2010)
Published in Clinical cancer research (01.01.2010)
Get full text
Journal Article
Challenges in developing a validated biomarker for angiogenesis inhibitors: the motesanib experience
Bass, Michael B, Yao, Bin, Hei, Yong-Jiang, Ye, Yining, Davis, Gerard J, Davis, Michael T, Kaesdorf, Barbara A, Chan, Sabrina S, Patterson, Scott D
Published in PloS one (14.10.2014)
Published in PloS one (14.10.2014)
Get full text
Journal Article
Primary overall survival (OS) from OPTiM, a randomized phase III trial of talimogene laherparepvec (T-VEC) versus subcutaneous (SC) granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment (tx) of unresected stage IIIB/C and IV melanoma
Kaufman, Howard L, Andtbacka, Robert Hans Ingemar, Collichio, Frances A., Amatruda, Thomas, Senzer, Neil N., Chesney, Jason, Delman, Keith A., Spitler, Lynn E., Puzanov, Igor, Ye, Yining, Li, Ai, Gansert, Jennifer L., Coffin, Robert, Ross, Merrick I.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
OPTiM: A randomized phase III trial of talimogene laherparepvec (T-VEC) versus subcutaneous (SC) granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment (tx) of unresected stage IIIB/C and IV melanoma
Andtbacka, Robert Hans Ingemar, Collichio, Frances A., Amatruda, Thomas, Senzer, Neil N., Chesney, Jason, Delman, Keith A., Spitler, Lynn E., Puzanov, Igor, Doleman, Susan, Ye, Yining, Vanderwalde, Ari M., Coffin, Robert, Kaufman, Howard
Published in Journal of clinical oncology (20.06.2013)
Published in Journal of clinical oncology (20.06.2013)
Get full text
Journal Article
Recurrent stroke risk is higher than cardiac event risk after initial stroke/transient ischemic attack
BROWN, Devin L, LISABETH, Lynda D, ROYCHOUDHURY, Canopy, YINING YE, MORGENSTERN, Lewis B
Published in Stroke (1970) (01.06.2005)
Published in Stroke (1970) (01.06.2005)
Get full text
Journal Article
Do licensing and accreditation matter in outpatient substance abuse treatment programs?
Wells, Rebecca, Ph.D, Lemak, Christy H., Ph.D, Alexander, Jeffrey A., Ph.D, Nahra, Tammie A., Ph.D, Ye, Yining, Ph.D, Campbell, Cynthia I., Ph.D
Published in Journal of substance abuse treatment (01.07.2007)
Published in Journal of substance abuse treatment (01.07.2007)
Get full text
Journal Article
Safety and Pharmacokinetics of Motesanib in Combination with Panitumumab and Gemcitabine-Cisplatin in Patients with Advanced Cancer
Burris, Howard, Stephenson, Joe, Otterson, Gregory A., Stein, Mark, McGreivy, Jesse, Sun, Yu-Nien, Ingram, Megan, Ye, Yining, Schwartzberg, Lee S.
Published in Journal of Oncology (2011)
Published in Journal of Oncology (2011)
Get full text
Journal Article
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Andtbacka, Robert H I, Kaufman, Howard L, Collichio, Frances, Amatruda, Thomas, Senzer, Neil, Chesney, Jason, Delman, Keith A, Spitler, Lynn E, Puzanov, Igor, Agarwala, Sanjiv S, Milhem, Mohammed, Cranmer, Lee, Curti, Brendan, Lewis, Karl, Ross, Merrick, Guthrie, Troy, Linette, Gerald P, Daniels, Gregory A, Harrington, Kevin, Middleton, Mark R, Miller, Jr, Wilson H, Zager, Jonathan S, Ye, Yining, Yao, Bin, Li, Ai, Doleman, Susan, VanderWalde, Ari, Gansert, Jennifer, Coffin, Robert S
Published in Journal of clinical oncology (01.09.2015)
Published in Journal of clinical oncology (01.09.2015)
Get full text
Journal Article
Expansion, Persistence and Pharmacodynamic Profile of ADI-001, a First-in-Class Allogeneic CD20-Targeted CAR Gamma Delta T Cell Therapy, in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
Moreno, Monica A, Kennedy-Wilde, Jackie, Wrong, Andrew D, Jahchan, Nadine, Galimi, Francesco, Ye, Yining, Lai, Rose, Aftab, Blake T
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Country Image in COVID-19 Pandemic: A Case Study of China
Chen, Huimin, Zhu, Zeyu, Qi, Fanchao, Ye, Yining, Liu, Zhiyuan, Sun, Maosong, Jin, Jianbin
Published in IEEE transactions on big data (01.03.2021)
Published in IEEE transactions on big data (01.03.2021)
Get full text
Journal Article
Abstract 2206: Anti-tumor activity of infigratinib, a potent and selective inhibitor of FGFR1, FGFR2 and FGFR3, in FGFR fusion-positive cholangiocarcinoma and other solid tumors
Li, Gary, Krook, Melanie, Roychowdhury, Sameek, Avogadri, Francesca, Ye, Yining, Moran, Susan
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article